<div id="readability-page-1"><div><p>Hangzhou Tigermed Consulting Co., Ltd reported earnings results for the full year ended December 31, 2025. For the full year, the company reported sales was CNY 6,832.8 million compared to CNY 6,603.12 million a year ago. Revenue was CNY 6,832.8 million compared to CNY 6,603.12 million a year ago.</p><p>Net income was CNY 887.89 million compared to CNY 405.14 million a year ago. Basic earnings per share from continuing operations was CNY 1.04 compared to CNY 0.47 a year ago. Diluted earnings per share from continuing operations was CNY 1.04 compared to CNY 0.47 a year ago.</p></div></div>

泰格醫藥

<p>杭州泰格醫藥諮詢有限公司公佈了截至 2025 年 12 月 31 日的全年財報。公司實現銷售額 68.328 億元人民幣，較去年 66.0312 億元人民幣有所增長。淨收入上升至 8.8789 億元人民幣，而去年為 4.0514 億元人民幣。持續經營業務的基本和攤薄每股收益均為 1.04 元人民幣，較去年 0.47 元人民幣有所增加</p>

杭州泰格醫藥諮詢有限公司公佈了截至2025年12月31日的全年財報結果